Novel Magnesium Oxide (MgO) nanoparticles (NPs) modified with the polymer poliethylene glycol (PEG) were synthesized as carrier for the anticancer drug 2-Methoxyestradiol (2ME) to improve its clinical application. The functionalized NPs were characterized by Infrared spectroscopy with Fourier transform to elucidate the vibration modes of this conjugate, indicating the formation of the MgO-PEG-2ME nanocomposite. The studies of absorption and liberation determined that MgO-PEG-2ME NPs incorporated 98.51 % of 2ME while liberation of 2ME was constant during 7 days at pH 2, 5 and 7.35. Finally, the MgO-PEG-2ME NPs decreased the viability of the prostate cancer cell line LNCap suggesting that this nanocomposite is suitable as a drug delivery system for anticancer prostate therapy.
12March 15, 2019 1/9 2-Metoxyestradiol (2ME) has antitumor activity in several types of cancer of the 13 reproductive tract as prostate, cervix, ovary or endometrium. 2ME exerts its anticancer 14 activity via anti-proliferative, apoptotic or antiangiogenic effects on tumor cells [7]. 15 Despite to be considerate as a promising anticancer drug it has an unfavorable kinetic 16 with a low solubility in water; Thus, it is necessary to find new ways to facilitate its 17 administration to the human body. In this context, the nanoparticles (NPs) as drug 18 carriers can play a fundamental role to improvement biological parameters. Actually, it 19 has been proposed that polymeric NPs [8] or TiO 2 NPs coated with polyethylene glycol 20 (PEG) could be useful tools to load 2ME [9]. In the searching for new NPs suitable for 21 medical use, MgO NPs are also an excellent candidate because they are bio-friendly [10]. 22 It has been shown that MgO NPs are not toxic for a variety of human cell lines at 23 concentrations under 300 µg/ml [10]. MgO NPs has been also used as a carrier for the 24 antincancer drug doxorubicin indicating its utility for a controlled system of drugs 25 delivery [11, 12]. In this work, we first performed the physicochemical characterization 26 of MgO NPs coated with PEG and loaded with 2ME (MgO-PEG-2ME). The efficiency 27 of absortion and liberation of 2ME was then analyzed. Finally, the effect of 28 MgO-PEG-2ME NPs on the prostate cell line LnCap was assessed. 29 Materials and Methods 30 Synthesis MgO nanoparticles 31 The MgO NPs were obtained by the sol-gel method route assisted with cetyltrimethyl 32 ammonium bromide C 19 H 4 2BrN (CTAB) as a surfactant to reduce the agglomeration of 33 the NPs [13]. 1:1 molar solution of magnesium acetate, Mg(CH 3 COO) 2 4H 2 O (99,5 %, 34 MERK, USA) and tartaric acid C 4 H 6 O 6 to (99,5 %, MERK, USA) was prepared in 35 ethanol and added dropwise over 10 ml of a 0.001 M of CTAB in water at 60 • C. The 36solution was stirred vigorously for 20 hours to achieve gel formation. Once the gel is 37 formed, it was dried and before calcined at 600 • C for 6 hours to give MgO [14].
38MgO nanoparticles functionalized with PEG and 2ME loading.
39MgO NPs were covered with poliethylene glycol 600 (PEG600; Sigma...